Keybank National Association OH Has $1.48 Million Holdings in Houlihan Lokey, Inc. $HLI

Keybank National Association OH lifted its holdings in Houlihan Lokey, Inc. (NYSE:HLI) by 138.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,505 shares of the financial services provider’s stock after purchasing an additional 4,932 shares during the period. Keybank National Association OH’s holdings in Houlihan Lokey were worth $1,481,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of HLI. Royal Bank of Canada lifted its stake in shares of Houlihan Lokey by 14.4% in the 1st quarter. Royal Bank of Canada now owns 49,584 shares of the financial services provider’s stock valued at $8,008,000 after purchasing an additional 6,253 shares during the last quarter. AQR Capital Management LLC lifted its stake in shares of Houlihan Lokey by 50.0% in the 1st quarter. AQR Capital Management LLC now owns 29,654 shares of the financial services provider’s stock valued at $4,598,000 after purchasing an additional 9,891 shares during the last quarter. Millennium Management LLC acquired a new stake in shares of Houlihan Lokey in the 1st quarter valued at $18,964,000. Goldman Sachs Group Inc. lifted its stake in shares of Houlihan Lokey by 5.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 415,743 shares of the financial services provider’s stock valued at $67,143,000 after purchasing an additional 22,553 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership acquired a new stake in shares of Houlihan Lokey in the 2nd quarter valued at $1,033,000. Institutional investors and hedge funds own 78.07% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on HLI. The Goldman Sachs Group cut their target price on shares of Houlihan Lokey from $210.00 to $184.00 and set a “buy” rating for the company in a research report on Wednesday, April 1st. BMO Capital Markets boosted their target price on shares of Houlihan Lokey from $209.00 to $211.00 and gave the stock an “outperform” rating in a research report on Thursday, January 29th. Morgan Stanley cut their target price on shares of Houlihan Lokey from $205.00 to $193.00 and set an “overweight” rating for the company in a research report on Thursday, April 9th. Weiss Ratings lowered shares of Houlihan Lokey from a “hold (c+)” rating to a “hold (c)” rating in a research report on Tuesday, April 21st. Finally, UBS Group cut their target price on shares of Houlihan Lokey from $196.00 to $163.00 and set a “neutral” rating for the company in a research report on Thursday, March 12th. Five investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, Houlihan Lokey presently has a consensus rating of “Moderate Buy” and an average target price of $197.71.

Insider Transactions at Houlihan Lokey

In related news, Director Robert A. Schriesheim sold 5,000 shares of the company’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $170.86, for a total value of $854,300.00. Following the sale, the director owned 27,982 shares of the company’s stock, valued at $4,781,004.52. The trade was a 15.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, General Counsel Christopher M. Crain sold 500 shares of the company’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $143.40, for a total transaction of $71,700.00. Following the completion of the sale, the general counsel directly owned 500 shares in the company, valued at approximately $71,700. The trade was a 50.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 22.83% of the company’s stock.

Houlihan Lokey Stock Performance

NYSE:HLI opened at $153.28 on Friday. The firm’s 50-day moving average is $151.46 and its 200-day moving average is $169.87. Houlihan Lokey, Inc. has a 52-week low of $134.41 and a 52-week high of $211.78. The company has a market cap of $10.70 billion, a price-to-earnings ratio of 23.55, a PEG ratio of 1.09 and a beta of 0.99.

Houlihan Lokey (NYSE:HLI) last posted its quarterly earnings data on Thursday, January 29th. The financial services provider reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Houlihan Lokey had a net margin of 16.91% and a return on equity of 24.46%. The business’s revenue was up 13.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.64 EPS. Equities analysts predict that Houlihan Lokey, Inc. will post 7.73 EPS for the current year.

About Houlihan Lokey

Houlihan Lokey, Inc is a global investment bank and financial services firm founded in 1972 and headquartered in Los Angeles, California. The company specializes in advisory services across a broad range of transaction types and financial matters. Since its founding, Houlihan Lokey has grown to serve corporations, financial sponsors, and government entities worldwide, providing expertise in complex and high-stakes engagements.

The firm’s core service offerings include mergers and acquisitions advisory, capital markets advisory, financial restructuring and distressed M&A, and valuation and fairness opinions.